Zoran Culig
Medizinische Universität Innsbruck
H-index: 74
Europe-Austria
Top articles of Zoran Culig
Clinical and basic research implications of the article ‘IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer’
Endocrine-Related Cancer
2024/5/1
Zoran Culig
H-Index: 38
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo …
BMC cancer
2024/3/19
Cholinergic signaling via muscarinic M1 receptor confers resistance to docetaxel in prostate cancer
Cell Reports Medicine
2024/2/20
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts
Oncogene
2024/1/19
Validation of a urine-based proteomics test to predict clinically significant prostate cancer: complementing MRI pathway
medRxiv
2024
Zoran Culig
H-Index: 38
MiRNA-mRNA integrative analysis reveals epigenetically regulated and prognostic miR-103a with a role in migration and invasion of carboplatin-resistant ovarian cancer cells …
Biomedicine & Pharmacotherapy
2023/10/1
Wei Zhang
H-Index: 23
Zoran Culig
H-Index: 38
The oncogenic protein kinase/ATPase RIOK1 is up-regulated via the c-myc/E2F transcription factor axis in prostate cancer
The American Journal of Pathology
2023/9/1
Florian Handle
H-Index: 11
Zoran Culig
H-Index: 38
Phenotypic plasticity, spatial niches and cancer-associated fibroblast/mural cell interactions define the human prostate cancer microenvironment
2023/8/26
Natalie Sampson
H-Index: 19
Georgios Fotakis
H-Index: 2
Zlatko Trajanoski
H-Index: 39
Zoran Culig
H-Index: 38
Heterogeneity and plasticity of prostate cancer
Frontiers in Molecular Biosciences
2023/6/14
Zoran Culig
H-Index: 38
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination
Cancers
2023/2/11
Zoran Culig
H-Index: 38
Androgen receptor antagonist Treatment of metastatic castration-resistant prostate cancer Treatment of metastatic breast cancer
DRUGS OF THE FUTURE
2023/1/1
Zoran Culig
H-Index: 38
Pruxelutamide. Androgen receptor antagonist, Treatment of metastatic castration-resistant prostate cancer, Treatment of metastatic breast cancer
Drugs of the Future
2023
Zoran Culig
H-Index: 38
Androgen receptor interacting proteins in prostate cancer development and therapy resistance
2023/12/15
Zoran Culig
H-Index: 38
Validation of diagnostic nomograms based on mass spectrometry-based urinary biomarkers to distinguish clinically significant prostate cancer: complementing MRI pathway
European Urology Open Science
2023/11/1
Validation of mass spectrometry-based biomarkers to detect clinically significant prostate cancer: A study based on non-invasive urine collection
European Urology Open Science
2023/10/1
MED12 promotes Prostate Cancer (PCa) cell proliferation through the Androgen Receptor (AR) signalling
European Urology Open Science
2023/10/1
Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients
British Journal of Cancer
2022/11/23
Zoran Culig
H-Index: 38
Antonio Alcaraz
H-Index: 17
Biochemical inhibition of the MYC down-stream target RIOK1 induces apoptosis in prostate cancer cells
European Urology Open Science
2022/10/1
Multicentric validation of nomograms based on urine peptide biomarkers for bladder cancer diagnostics and monitoring in two prospective cohorts of patients
European Urology Open Science
2022/10/1
Diagnostic nomograms based on CE-MS urinary biomarkers to detect clinically significant prostate cancer
European Urology Open Science
2022/10/1
